Recipe Control, Verification and Error Capture — Artificial Intelligence in Pharmacy

Gains:

Ability to pre-scan dosage, indication, duplication and interaction risks in the prescription with artificial intelligence and flag suspicious items
Ability to manage the risk of false positives/negatives by confirming each alert captured by artificial intelligence with the SmPC, guide and physician
Prescription approval is the responsibility of the competent pharmacist and in case of doubt, the ability to apply the chain of consultation to the physician.

The prescription is the bridge that transfers the physician's decision to the pharmacist's practice; But the pharmacist checks each board of this bridge separately. Incorrect dose, repeated medication, an overlooked interaction, an indication that does not suit the patient; All of this is caught in the prescription check. This task is repeated dozens of times per hour in a busy pharmacy, and attention fatigue is a real risk. Artificial intelligence is valuable here as a second eye: it flags suspicious items, highlights a risk that might be overlooked, reminds you of the checklist. But AI can produce a false positive (unnecessary alarm) or false negative (miss); so every warning of his must also be verified. In this unit, you will learn how to make artificial intelligence a safe second eye in prescription control.

Dimensions of prescription control

A good prescription check asks these questions:

Is it the right medicine? Is the indication (reason for use) appropriate for the patient? Is there confusion due to similarity of names (e.g. two similar drug names)?
Is it the right dose? Is the dose appropriate according to age, weight, kidney/liver function? Has the maximum dose been exceeded?
Is there any duplication? Are two products containing the same active ingredient prescribed together?
Is there interaction? Interaction with prescribed medications or others the patient is taking?
Are there any contraindications? Is the medication harmful due to a patient's condition (pregnancy, allergy, disease)?
Are the duration and amount consistent? Is the number of boxes written compatible with the dose and duration?

AI can pre-screen each of these dimensions; But every finding is confirmed with the SmPC, the guide and, when necessary, the physician.

Among these dimensions, the most insidious one is the confusion caused by the similarity of names (LASA in international literature: drugs with similar spelling or pronunciation). Two different active ingredients that resemble each other by just a few letters can be confused due to handwriting or quick selection, and such an error leads to a completely different treatment. AI can remind you if the drug name in a prescription has a known “miscible pair”; But the decision of which one is actually meant is made by the patient's diagnosis and clarification with the physician when necessary. The artificial intelligence's warning that "it may be mixed with that medicine" is a beginning, not an end.

Caution: AI may incorrectly decipher an abbreviation in the prescription or calculate a dose from a different form. Just because he says "no problem" doesn't prove that the prescription is correct; He only gives a sign based on what he sees.

False positive and false negative

There are two types of errors in prescription control. A false positive is raising an alarm when there is actually no problem; If it happens too frequently, it creates "alarm fatigue" and real warnings are ignored. A false negative is missing a real problem; This is more dangerous because it passes silently. AI can produce both. That's why you can't make AI the only control layer; it is a complement to the pharmacist's control, not a replacement.

three mini cases

Case 1 — Duplicate active ingredient. One prescription contained a painkiller containing the same active ingredient under two different trade names; If the patient took both together, the dose would be doubled. Artificial intelligence flagged "possible duplicate active ingredient" in the pre-screening. The pharmacist verified the contents of the two products on the SmPC, confirmed the duplication, and canceled one of them in consultation with the physician. Artificial intelligence highlighted a risk that could have been overlooked.

Case 2 — False positive interaction. The AI warned of "serious interaction" in one prescription. When the pharmacist looked at the current interaction database, he saw that this was a theoretically and clinically insignificant interaction; The dose and monitoring of the patient were already safe. The pharmacist recorded the warning as "evaluated, no intervention is required". If artificial intelligence were blindly followed, there would be an unnecessary search for a doctor and patient anxiety.

Case 3 — Dose-duration discrepancy. In the syrup prescribed for a child, the daily dose and duration of treatment were given, but the number of prescribed bottles was not enough to complete the treatment. Artificial intelligence gave a warning that "the amount may not cover the treatment period". The pharmacist verified the account, confirmed the deficiency, and corrected the amount with the physician. Artificial intelligence caught an arithmetic discrepancy.

Step by step recipe control (artificial intelligence supported)

Anonymize. Clear patient ID; let alone the clinical context.
Do your own check. As the pharmacist, you evaluate the prescription first.
Ask for a second eye. Request AI pre-screening for dose, duplication, interaction and consistency.
Filter alerts. Weigh each alert against the SmPC/database; Weed out false positive.
If you are at real risk, consult your doctor. Resolve the confirmed problem with a physician.
Record the decision and justification. Make both captured and eliminated alerts traceable.

Weak prompt / Strong prompt

Weak: "Is this prescription correct?"

Strong: "Pre-screen the following prescription as a pharmacist's second eye. Patient (anonymous): 70 years old, creatinine clearance ~30 mL/min, known allergy [...]. Prescription: [drug/dose/duration list]. Flag suspicious items under the following headings: dose appropriateness, duplicate active ingredient, interaction, contraindication, amount-duration consistency. For each flag 'Confirm with SmPC/database 'et' and give the importance level (high/medium/low) decision."

The patient context, control headings and verification condition are clear in the powerful prompt.

Four copyable templates

Task: Duplicate active ingredient screening.Drug list (trade names): [...].Output: Mark duplicates that may contain the same active ingredient; add note "content must be verified from SmPC". If you are not sure, write [UNCERTAIN].

Task: Dose-amount-duration consistency check.Input: dose [...], frequency [...], duration [...] days, prescription quantity [...].Calculate: total units required etc. prescription amount. Mark any discrepancies. Show the calculation step by step; The pharmacist will independently verify.

Task: Contraindication checklist.Patient conditions: [pregnancy/allergy/illness]. Drugs: [...].Output: For each drug "could this conflict with the situation?" Mark the question; do not make a final judgment, write "confirm in the contraindication section of the SmPC".

Recipe control layers table

layer

Who/what does

Purpose

1. Pharmacist first reading

Pharmacist

Clinical logic and integrity

2. Artificial intelligence pre-screening

artificial intelligence

Mark what you missed

3. Source confirmation

Pharmacist + SPC/database

proof of accuracy

4. Physician communication

Pharmacist ↔ Physician

Solving the real problem

5. Registration

Pharmacist

traceability

Common mistakes

Relaxing because the artificial intelligence said 'no problem'. There is a risk of false negatives; Pharmacist control is essential.
Blindly obeying every warning. False positives should be eliminated and unnecessary physician searches should be prevented.
Decoding abbreviations by artificial intelligence. If prescription abbreviations are unclear, the physician should be asked.
Skipping quantity-duration calculation. Simple arithmetic inconsistencies disrupt patient compliance.
Not recording the decision. Eliminated and captured alerts must be traceable.

In summary

Artificial intelligence is a valuable second eye in prescription control; It establishes a safety net against attention fatigue by flagging risks of dosage, duplication, interaction, and consistency. But it cannot be the only control layer as it can produce both false positives and false negatives. The pharmacist first makes his own evaluation, filters the warnings of the artificial intelligence with the SmPC and database, solves the real problem with the physician and records the decision. The responsibility for prescription approval always lies with the competent pharmacist.

Application task

Set up an anonymous prescription scenario (patient context + 4-5 items, include intentional duplication and a dose-time discrepancy). Ask the AI for a second eye pre-scan. List the problems it catches and misses; Show with the SmPC/database which of the alerts it produces are false positives. Finally, write down the physician communication you will use to solve the real problems caught and how you will record them.

checklist

[ ] I evaluated the prescription myself first.
[ ] I gave the patient context anonymously and completely.
[ ] I received a structured pre-scan from the AI.
[ ] I confirmed each alert with the SmPC/database.
[ ] I eliminated false positives with justification.
[ ] I solved the real problem with the doctor.
[ ] I recorded the alerts that were caught and eliminated.